SynthesisInternational journal of colorectal disease2020

Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.

What the trial testedas reported · 2020

Not counted

−20%−33% to −5%

Bigger than 6 in 10 for all-cause mortality

As reported

HR 0.80, 95% CI 0.67–0.95 · the paper's word: All-cause mortality

Range includes no effect

−16%−35% to +8%

Bigger than 5 in 10 for all-cause mortality

As reported

HR 0.84, 95% CI 0.65–1.08 · the paper's word: All-cause mortality

the abstract, start to end

… T2DM who did not receive metformin (HR = 0.80, 95% CI 0.67-0.95).

… metformin and those who did not (HR = 0.84, 95% CI 0.65-1.08).

← favours treatmentfavours comparator →

could be chance

All-cause mortality

HR 0.800.67–0.95

All-cause mortality

HR 0.840.65–1.08

MetforminAll-cause mortality

1 / 3

2020

2021

2022

2023

2024

2025

this papercites it